Avidian Wealth Enterprises’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,600	Closed	-$369K	–	460
2022 Q3	$369K	Buy	+6,600	New	+$369K	0.03%	279
2022 Q1	–	Sell	-1,700	Closed	-$201K	–	536
2021 Q4	$201K	Buy	+1,700	New	+$201K	0.01%	486